Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.
about
Biologic Approaches to Treat Substance-Use DisordersNovel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierNew directions in nicotine vaccine design and use.Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceImmunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditionsEffects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.Tobacco use and cessation for cancer survivors: an overview for cliniciansEvaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapiesImmunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.A simple physiologically based pharmacokinetic model evaluating the effect of anti-nicotine antibodies on nicotine disposition in the brains of rats and humans.Biologics to treat substance use disorders: Current status and new directionsCurrent status and future prospects for the development of substance abuse vaccines.Treatment with a nicotine vaccine does not lead to changes in brain activity during smoking cue exposure or a working memory task.Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
P2860
Q28085073-DFECAD46-679F-417C-915D-5655A474942BQ28542642-3CF8E5BD-09AB-485D-B137-7378FAEBC8C5Q33719424-1C075CF3-CE76-4E2F-A5FE-A15831B3D6E3Q33751968-310DC2E9-0314-4C58-8773-3DA8755BA5FEQ35009554-C9879E8F-8A7E-43B5-931A-BC91251411C0Q35061547-29EDFE4D-A7E5-43A9-86CF-D7CED94F5552Q35207004-8F090628-E295-4B0A-A06C-A228C79B43F1Q35226577-16582AB5-B6A4-4855-B44C-71AA0B90878BQ35637965-D86E1411-FACF-4CC5-B79A-FFA1BD3B84C2Q35694111-3387F321-D385-4B03-97E7-FB871F53D489Q36933639-8BE98CF2-2045-4DD7-AE70-3E3FB8B8BF2EQ39544975-978054A7-4E6C-4069-AB9F-0A8D053B7761Q39576940-E6D6F9F3-E6DB-4DD9-8D19-424E24F779B8Q43076031-817AE3E9-0E92-4FA3-87FE-B72E3FDEB89DQ48737750-A41EEA1A-912D-4A06-BC37-C24E6480E4A8Q58691808-79D982DE-6999-4D3E-ACE6-A14BA91BC7B7
P2860
Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@ast
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@en
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@nl
type
label
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@ast
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@en
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@nl
prefLabel
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@ast
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@en
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@nl
P2093
P2860
P1476
Effect of a nicotine vaccine o ...... vivo in human tobacco smokers.
@en
P2093
D Cyril D'Souza
Dorothy M Hatsukami
Evgenia Perkins
Frederic Bois
Irina Esterlis
John P Seibyl
Jonas O Hannestad
Kelly P Cosgrove
Rachel F Tyndale
Stephanie S O'Malley
P2860
P304
P356
10.1176/APPI.AJP.2012.12060793
P407
P577
2013-04-01T00:00:00Z